Works matching IS 22285652 AND DT 2024 AND VI 14 AND IP 4
Results: 8
Interaction of toll-like receptors and ACE-2 with different variants of SARS-CoV-2: A computational analysis.
- Published in:
- BioImpacts, 2024, v. 14, n. 4, p. 1, doi. 10.34172/bi.2024.30150
- By:
- Publication type:
- Article
Unveiling the biological effects of radio-frequency and extremelylow frequency electromagnetic fields on the central nervous system performance.
- Published in:
- BioImpacts, 2024, v. 14, n. 4, p. 1, doi. 10.34172/bi.2023.30064
- By:
- Publication type:
- Article
Cancer treatment comes to age: from one-size-fits-all to nextgeneration sequencing (NGS) technologies.
- Published in:
- BioImpacts, 2024, v. 14, n. 4, p. 1, doi. 10.34172/bi.2023.29957
- By:
- Publication type:
- Article
Thiazolo-pyridopyrimidines: An in silico evaluation as a lead for CDK4/6 inhibition, synthesis and cytotoxicity screening against breast cancer cell lines.
- Published in:
- BioImpacts, 2024, v. 14, n. 4, p. 1, doi. 10.34172/bi.2023.29951
- By:
- Publication type:
- Article
Design and implementation of a lab-on-a-chip for assisted reproductive technologies.
- Published in:
- BioImpacts, 2024, v. 14, n. 4, p. 1, doi. 10.34172/bi.2023.28902
- By:
- Publication type:
- Article
Integrating rapamycin with novel PI3K/Akt/mTOR inhibitor microRNAs on NOTCH1-driven T-cell acute lymphoblastic leukemia (T-ALL).
- Published in:
- BioImpacts, 2024, v. 14, n. 4, p. 1, doi. 10.34172/bi.2023.28870
- By:
- Publication type:
- Article
New approach to generating of human monoclonal antibodies specific to the proteolytic domain of botulinum neurotoxin A.
- Published in:
- BioImpacts, 2024, v. 14, n. 4, p. 1, doi. 10.34172/bi.2023.27680
- By:
- Publication type:
- Article
Telomerase and mitochondria inhibition promote apoptosis and TET2 and ANMT3a expression in triple negative breast cancer cell lines.
- Published in:
- BioImpacts, 2024, v. 14, n. 4, p. 1, doi. 10.34172/bi.2023.27640
- By:
- Publication type:
- Article